Monday, January 18, 2021
Search

Johnson - search results

If you're not happy with the results, please do another search

Drug Companies Lobbying To Raise Drug Prices For Senior Citizens

Major pharmaceutical companies just can’t seem to get enough cash, and they are now lobbying the federal government to get Medicare drug discounts for...

FDA Approves New Indication for Xarelto

New Jersey-based drugmaker Johnson & Johnson (JNJ) and its partner, Bayer AG, received approval for a new indication for the controversial anti-coagulant medication Xarelto...

Xarelto Fails to Prevent Clotting in Recent Trial

Johnson & Johnson’s and Bayer's recent attempt to expand the market for its controversial anticoagulant, Xarelto, encountered a setback when the medication failed to...

Jury Awards $4.6 Billion in Talcum Powder Cancer Case

Johnson & Johnson recently got hit with nearly five billion dollars by a jury for covering up the dangers of their talcum powder products....

The First Glyphosate Cancer Lawsuit Trial Begins This Week

46-year-old DeWayne Johnson of Bernicia, California is a husband and father of three children. He worked for the local school district as a groundskeeper...

Why Has Pfizer Discontinued Research on Neurodegenerative Diseases?

In January, pharmaceutical giant Pfizer announced that it would stop all funding for research into neurodegenerative diseases, specifically Parkinson's and Alzheimer's. In a media...

Investigation by a U.S. Senator Reveals Pharmaceutical Companies Paid Big Bucks in Order to...

As the current federal Administration under its current poor excuse for leadership continues to flail about incompetently in the face of the nation's opioid...

Light Therapy and Bipolar Disorder – Will it Work?

Phototherapy – better known as “light therapy” – has long been used for treating a form of depression known as “Seasonal Affective Disorder” (SAD),...

Conflicting Data on Invokana and Kidney Injuries: Manufacturer’s Study Shows “Improved Renal Outcomes,” Independent...

Patients with Type 2 diabetes who take the prescription medication Invokana (canagliflozin) either experience “significantly improved renal outcomes” or risk severe kidney damage –...

New Study Shows That Xarelto is No Better Than Aspirin for Preventing Secondary Stroke

A recent clinical study intended to demonstrate the superiority of Xarelto (rivaroxaban) to aspirin in the prevention of secondary stroke has been abandoned by...